Global Oral Rabies Vaccine Market Research Report 2023

Industry: Pharma & Healthcare

Published: 2023-07-28

Pages: 71 Pages

Report ld: 1564718

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

According to QYResearch’s new survey, global Oral Rabies Vaccine market is projected to reach US$ 297 million in 2029, increasing from US$ 80 million in 2022, with the CAGR of 20.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Rabies Vaccine market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Rabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
    Boehringer Ingelheim(Merial)
    Ceva Santé Animale(Artemis Technologies)
    Virbac

Segment by Type
    Modified Live Virus
    Recombinant Vaccinia
    Recombinant Adenovirus Vaccine

Segment by Application
    Government
    Commercial

Consumption by Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Southeast Asia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

The Oral Rabies Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

undefined

Table of Contents

1 Oral Rabies Vaccine Market Overview
    1.1 Product Overview and Scope of Oral Rabies Vaccine
    1.2 Oral Rabies Vaccine Segment by Type
        1.2.1 Global Oral Rabies Vaccine Market Value Comparison by Type (2023-2029)
        1.2.2 Modified Live Virus
        1.2.3 Recombinant Vaccinia
        1.2.4 Recombinant Adenovirus Vaccine
    1.3 Oral Rabies Vaccine Segment by Application
        1.3.1 Global Oral Rabies Vaccine Market Value by Application: (2023-2029)
        1.3.2 Government
        1.3.3 Commercial
    1.4 Global Oral Rabies Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Oral Rabies Vaccine Revenue 2018-2029
        1.4.2 Global Oral Rabies Vaccine Sales 2018-2029
        1.4.3 Global Oral Rabies Vaccine Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

2 Oral Rabies Vaccine Market Competition by Manufacturers
    2.1 Global Oral Rabies Vaccine Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Oral Rabies Vaccine Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Oral Rabies Vaccine Average Price by Manufacturers (2018-2023)
    2.4 Global Oral Rabies Vaccine Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Oral Rabies Vaccine, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Oral Rabies Vaccine, Product Type & Application
    2.7 Oral Rabies Vaccine Market Competitive Situation and Trends
        2.7.1 Oral Rabies Vaccine Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Oral Rabies Vaccine Players Market Share by Revenue
        2.7.3 Global Oral Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oral Rabies Vaccine Retrospective Market Scenario by Region
    3.1 Global Oral Rabies Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Oral Rabies Vaccine Global Oral Rabies Vaccine Sales by Region: 2018-2029
        3.2.1 Global Oral Rabies Vaccine Sales by Region: 2018-2023
        3.2.2 Global Oral Rabies Vaccine Sales by Region: 2024-2029
    3.3 Global Oral Rabies Vaccine Global Oral Rabies Vaccine Revenue by Region: 2018-2029
        3.3.1 Global Oral Rabies Vaccine Revenue by Region: 2018-2023
        3.3.2 Global Oral Rabies Vaccine Revenue by Region: 2024-2029
    3.4 North America Oral Rabies Vaccine Market Facts & Figures by Country
        3.4.1 North America Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Oral Rabies Vaccine Sales by Country (2018-2029)
        3.4.3 North America Oral Rabies Vaccine Revenue by Country (2018-2029)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Oral Rabies Vaccine Market Facts & Figures by Country
        3.5.1 Europe Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Oral Rabies Vaccine Sales by Country (2018-2029)
        3.5.3 Europe Oral Rabies Vaccine Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Oral Rabies Vaccine Market Facts & Figures by Country
        3.6.1 Asia Pacific Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Oral Rabies Vaccine Sales by Country (2018-2029)
        3.6.3 Asia Pacific Oral Rabies Vaccine Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America Oral Rabies Vaccine Market Facts & Figures by Country
        3.7.1 Latin America Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Oral Rabies Vaccine Sales by Country (2018-2029)
        3.7.3 Latin America Oral Rabies Vaccine Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Oral Rabies Vaccine Market Facts & Figures by Country
        3.8.1 Middle East and Africa Oral Rabies Vaccine Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Oral Rabies Vaccine Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Oral Rabies Vaccine Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

4 Segment by Type
    4.1 Global Oral Rabies Vaccine Sales by Type (2018-2029)
        4.1.1 Global Oral Rabies Vaccine Sales by Type (2018-2023)
        4.1.2 Global Oral Rabies Vaccine Sales by Type (2024-2029)
        4.1.3 Global Oral Rabies Vaccine Sales Market Share by Type (2018-2029)
    4.2 Global Oral Rabies Vaccine Revenue by Type (2018-2029)
        4.2.1 Global Oral Rabies Vaccine Revenue by Type (2018-2023)
        4.2.2 Global Oral Rabies Vaccine Revenue by Type (2024-2029)
        4.2.3 Global Oral Rabies Vaccine Revenue Market Share by Type (2018-2029)
    4.3 Global Oral Rabies Vaccine Price by Type (2018-2029)

5 Segment by Application
    5.1 Global Oral Rabies Vaccine Sales by Application (2018-2029)
        5.1.1 Global Oral Rabies Vaccine Sales by Application (2018-2023)
        5.1.2 Global Oral Rabies Vaccine Sales by Application (2024-2029)
        5.1.3 Global Oral Rabies Vaccine Sales Market Share by Application (2018-2029)
    5.2 Global Oral Rabies Vaccine Revenue by Application (2018-2029)
        5.2.1 Global Oral Rabies Vaccine Revenue by Application (2018-2023)
        5.2.2 Global Oral Rabies Vaccine Revenue by Application (2024-2029)
        5.2.3 Global Oral Rabies Vaccine Revenue Market Share by Application (2018-2029)
    5.3 Global Oral Rabies Vaccine Price by Application (2018-2029)

6 Key Companies Profiled
    6.1 Boehringer Ingelheim(Merial)
        6.1.1 Boehringer Ingelheim(Merial) Corporation Information
        6.1.2 Boehringer Ingelheim(Merial) Description and Business Overview
        6.1.3 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product Portfolio
        6.1.5 Boehringer Ingelheim(Merial) Recent Developments/Updates
    6.2 Ceva Santé Animale(Artemis Technologies)
        6.2.1 Ceva Santé Animale(Artemis Technologies) Corporation Information
        6.2.2 Ceva Santé Animale(Artemis Technologies) Description and Business Overview
        6.2.3 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product Portfolio
        6.2.5 Ceva Santé Animale(Artemis Technologies) Recent Developments/Updates
    6.3 Virbac
        6.3.1 Virbac Corporation Information
        6.3.2 Virbac Description and Business Overview
        6.3.3 Virbac Oral Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Virbac Oral Rabies Vaccine Product Portfolio
        6.3.5 Virbac Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
    7.1 Oral Rabies Vaccine Industry Chain Analysis
    7.2 Oral Rabies Vaccine Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Oral Rabies Vaccine Production Mode & Process
    7.4 Oral Rabies Vaccine Sales and Marketing
        7.4.1 Oral Rabies Vaccine Sales Channels
        7.4.2 Oral Rabies Vaccine Distributors
    7.5 Oral Rabies Vaccine Customers

8 Oral Rabies Vaccine Market Dynamics
    8.1 Oral Rabies Vaccine Industry Trends
    8.2 Oral Rabies Vaccine Market Drivers
    8.3 Oral Rabies Vaccine Market Challenges
    8.4 Oral Rabies Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Rabies Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Oral Rabies Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Oral Rabies Vaccine Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Oral Rabies Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Oral Rabies Vaccine Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Oral Rabies Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Oral Rabies Vaccine Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Oral Rabies Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Oral Rabies Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Oral Rabies Vaccine, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Oral Rabies Vaccine, Product Type & Application
    Table 12. Global Key Manufacturers of Oral Rabies Vaccine, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Oral Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Rabies Vaccine as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Oral Rabies Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Oral Rabies Vaccine Sales by Region (2018-2023) & (K Units)
    Table 18. Global Oral Rabies Vaccine Sales Market Share by Region (2018-2023)
    Table 19. Global Oral Rabies Vaccine Sales by Region (2024-2029) & (K Units)
    Table 20. Global Oral Rabies Vaccine Sales Market Share by Region (2024-2029)
    Table 21. Global Oral Rabies Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Oral Rabies Vaccine Revenue Market Share by Region (2018-2023)
    Table 23. Global Oral Rabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Oral Rabies Vaccine Revenue Market Share by Region (2024-2029)
    Table 25. North America Oral Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 27. North America Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 28. North America Oral Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Oral Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Oral Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Oral Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Oral Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Oral Rabies Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Oral Rabies Vaccine Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Oral Rabies Vaccine Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Oral Rabies Vaccine Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Oral Rabies Vaccine Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Oral Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Oral Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Oral Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Oral Rabies Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Oral Rabies Vaccine Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Oral Rabies Vaccine Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Oral Rabies Vaccine Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Oral Rabies Vaccine Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Oral Rabies Vaccine Sales (K Units) by Type (2018-2023)
    Table 51. Global Oral Rabies Vaccine Sales (K Units) by Type (2024-2029)
    Table 52. Global Oral Rabies Vaccine Sales Market Share by Type (2018-2023)
    Table 53. Global Oral Rabies Vaccine Sales Market Share by Type (2024-2029)
    Table 54. Global Oral Rabies Vaccine Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Oral Rabies Vaccine Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Oral Rabies Vaccine Revenue Market Share by Type (2018-2023)
    Table 57. Global Oral Rabies Vaccine Revenue Market Share by Type (2024-2029)
    Table 58. Global Oral Rabies Vaccine Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Oral Rabies Vaccine Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Oral Rabies Vaccine Sales (K Units) by Application (2018-2023)
    Table 61. Global Oral Rabies Vaccine Sales (K Units) by Application (2024-2029)
    Table 62. Global Oral Rabies Vaccine Sales Market Share by Application (2018-2023)
    Table 63. Global Oral Rabies Vaccine Sales Market Share by Application (2024-2029)
    Table 64. Global Oral Rabies Vaccine Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Oral Rabies Vaccine Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Oral Rabies Vaccine Revenue Market Share by Application (2018-2023)
    Table 67. Global Oral Rabies Vaccine Revenue Market Share by Application (2024-2029)
    Table 68. Global Oral Rabies Vaccine Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Oral Rabies Vaccine Price (US$/Unit) by Application (2024-2029)
    Table 70. Boehringer Ingelheim(Merial) Corporation Information
    Table 71. Boehringer Ingelheim(Merial) Description and Business Overview
    Table 72. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product
    Table 74. Boehringer Ingelheim(Merial) Recent Developments/Updates
    Table 75. Ceva Santé Animale(Artemis Technologies) Corporation Information
    Table 76. Ceva Santé Animale(Artemis Technologies) Description and Business Overview
    Table 77. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product
    Table 79. Ceva Santé Animale(Artemis Technologies) Recent Developments/Updates
    Table 80. Virbac Corporation Information
    Table 81. Virbac Description and Business Overview
    Table 82. Virbac Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Virbac Oral Rabies Vaccine Product
    Table 84. Virbac Recent Developments/Updates
    Table 85. Key Raw Materials Lists
    Table 86. Raw Materials Key Suppliers Lists
    Table 87. Oral Rabies Vaccine Distributors List
    Table 88. Oral Rabies Vaccine Customers List
    Table 89. Oral Rabies Vaccine Market Trends
    Table 90. Oral Rabies Vaccine Market Drivers
    Table 91. Oral Rabies Vaccine Market Challenges
    Table 92. Oral Rabies Vaccine Market Restraints
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Oral Rabies Vaccine
    Figure 2. Global Oral Rabies Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Oral Rabies Vaccine Market Share by Type in 2022 & 2029
    Figure 4. Modified Live Virus Product Picture
    Figure 5. Recombinant Vaccinia Product Picture
    Figure 6. Recombinant Adenovirus Vaccine Product Picture
    Figure 7. Global Oral Rabies Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Oral Rabies Vaccine Market Share by Application in 2022 & 2029
    Figure 9. Government
    Figure 10. Commercial
    Figure 11. Global Oral Rabies Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Oral Rabies Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 13. Global Oral Rabies Vaccine Sales (2018-2029) & (K Units)
    Figure 14. Global Oral Rabies Vaccine Average Price (US$/Unit) & (2018-2029)
    Figure 15. Oral Rabies Vaccine Report Years Considered
    Figure 16. Oral Rabies Vaccine Sales Share by Manufacturers in 2022
    Figure 17. Global Oral Rabies Vaccine Revenue Share by Manufacturers in 2022
    Figure 18. The Global 5 and 10 Largest Oral Rabies Vaccine Players: Market Share by Revenue in 2022
    Figure 19. Oral Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 20. Global Oral Rabies Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 21. North America Oral Rabies Vaccine Sales Market Share by Country (2018-2029)
    Figure 22. North America Oral Rabies Vaccine Revenue Market Share by Country (2018-2029)
    Figure 23. United States Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 24. Canada Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Europe Oral Rabies Vaccine Sales Market Share by Country (2018-2029)
    Figure 26. Europe Oral Rabies Vaccine Revenue Market Share by Country (2018-2029)
    Figure 27. Germany Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. France Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. U.K. Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Italy Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Russia Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Asia Pacific Oral Rabies Vaccine Sales Market Share by Region (2018-2029)
    Figure 33. Asia Pacific Oral Rabies Vaccine Revenue Market Share by Region (2018-2029)
    Figure 34. China Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Japan Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. South Korea Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. India Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Australia Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. China Taiwan Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Southeast Asia Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Latin America Oral Rabies Vaccine Sales Market Share by Country (2018-2029)
    Figure 42. Latin America Oral Rabies Vaccine Revenue Market Share by Country (2018-2029)
    Figure 43. Mexico Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Brazil Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Argentina Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Oral Rabies Vaccine Sales Market Share by Country (2018-2029)
    Figure 47. Middle East & Africa Oral Rabies Vaccine Revenue Market Share by Country (2018-2029)
    Figure 48. Turkey Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Saudi Arabia Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. UAE Oral Rabies Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Global Sales Market Share of Oral Rabies Vaccine by Type (2018-2029)
    Figure 52. Global Revenue Market Share of Oral Rabies Vaccine by Type (2018-2029)
    Figure 53. Global Oral Rabies Vaccine Price (US$/Unit) by Type (2018-2029)
    Figure 54. Global Sales Market Share of Oral Rabies Vaccine by Application (2018-2029)
    Figure 55. Global Revenue Market Share of Oral Rabies Vaccine by Application (2018-2029)
    Figure 56. Global Oral Rabies Vaccine Price (US$/Unit) by Application (2018-2029)
    Figure 57. Oral Rabies Vaccine Value Chain
    Figure 58. Oral Rabies Vaccine Production Process
    Figure 59. Channels of Distribution (Direct Vs Distribution)
    Figure 60. Distributors Profiles
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Description

According to QYResearch’s new survey, global Oral Rabies Vaccine market is projected to reach US$ 297 million in 2029, increasing from US$ 80 million in 2022, with the CAGR of 20.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Rabies Vaccine market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Rabies Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
    Boehringer Ingelheim(Merial)
    Ceva Santé Animale(Artemis Technologies)
    Virbac

Segment by Type
    Modified Live Virus
    Recombinant Vaccinia
    Recombinant Adenovirus Vaccine

Segment by Application
    Government
    Commercial

Consumption by Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Southeast Asia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

The Oral Rabies Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

undefined

Related Reports

Global Oral Rabies Vaccine Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
Oral Rabies Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impa
Published: 2023-07-29
Pages: 73
USD 3350.00
(Single User License)
Global Oral Rabies Vaccine Market Insights, Forecast to 2029
Global Oral Rabies Vaccine market is expected to reach to US$ 98 million in 2023, with a positive gr
Published: 2023-08-28
Pages: 77
USD 4900.00
(Single User License)
Oral Rabies Vaccine - Global Market Insights and Sales Trends 2024
The global Oral Rabies Vaccine market size is expected to reach US$ 297 million by 2029, growing at
Published: 2023-12-29
Pages: 74
USD 3350.00
(Single User License)
Oral Rabies Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Oral Rabies Vaccine was estimated to be worth US$ 80 million in 2023 and is fo
Published: 2024-02-19
Pages: 82
USD 3950.00
(Single User License)
Global Oral Rabies Vaccine Market Research Report 2025
The global market for Oral Rabies Vaccine was valued at US$ 116 million in the year 2024 and is proj
Published: 2025-03-02
Pages: 70
USD 2900.00
(Single User License)
Oral Rabies Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oral Rabies Vaccine was estimated to be worth US$ 116 million in 2024 and is f
Published: 2025-03-02
Pages: 84
USD 3950.00
(Single User License)